New investors may be looking at the soaring stock market and wondering if now is a good time to try and get in on the action. Leaping into the market without proper research or a solid plan may leave the investor on the short end of the stick. Creating a stock investing plan can be as simple or complex as the individual chooses. Sometimes, keeping things simple may be the best way to go. Other times, there may be more than meets the eye, and a deep-dive into the crucial data may be required. New investors may be extremely excited to start buying stocks. They may have heard some great water cooler talk about the next big stock. There is always a possibility that the hot stock chatter may end up coming to fruition, but it could just as likely turn out to be terribly erroneous. Many individuals in the financial world will be quick to provide these can’t lose picks, but until this information is thoroughly researched, investors may want to proceed with caution.

Putting a closer focus on shares of Epizyme, Inc. (NASDAQ:EPZM), we see that since the opening price of 12.31, the stock has moved 0.04. Tracking shares, we note that the consensus stock rating is Strong Buy. Volume today clocks in around 193163. Over the course of the current session, the stock has topped out at 12.4 and seen a low price of 12.05. Investors will be putting 3/14/2019 on the schedule as the company is slated to next report earnings around that date.

Taking a look at some historical highs and lows for Epizyme, Inc. (NASDAQ:EPZM), we see that the all time high is currently 45.72, and the all time low is 5.14. Investors often pay added attention to a stock when it is nearing a historical high point or low point. For the last year, the high price is 21.4, and the low price stands at 5.14. For the last six months, the high was seen at 12.4, and the low was tracked at 5.14. If we move in closer, the three month high/low is 12.4/5.14, and the one month high/low is 12.4/8.8.

Traders following the stock may be watching SMA or Simple Moving Average Levels. Many traders will be watching out for when the shorter-term averages cross above the longer-term averages as this may point to the start of an uptrend. Let’s look at the following SMA readings for Epizyme, Inc. (NASDAQ:EPZM):

SMA 50 day: 10.07873
SMA 30 day: 10.4098835
SMA 200 day: 8.473515
SMA 20 day: 11.038315
SMA 100 day: 8.205266
SMA 10 day11.77463

Traders following the Chaikin Money Flow indicator will note that the current 20 day reading is 0.4815886. The CMF value will fluctuate between 1 and -1. In general, a value closer to 1 would indicate higher buying pressure. A value closer to -1 would represent higher selling pressure.

Technical analysis on the stock may include following the Keltner Channels indicator. Currently, the 20 day upper band is 11.569572. The 20 day lower band is noted at 10.7799225. The KC indicator is considered a lagging indicator. Traders may use the values to help spot overbought and oversold conditions.

Traders have the ability to use a wide range of indicators when studying stocks. Each trader will typically find a few indicators that they heavily rely on. The Ichimoku Cloud indicator works to identify trend direction, gauge momentum, and identify trading opportunities based on crossovers. We can view some Ichimoku indicator levels below:

Ichimoku Lead 1: 8.8625
Ichimoku Lead 2: 7.805
Ichimoku Cloud Base Line: 10.62
Ichimoku Cloud Conversion Line: 11.81

Traders following the Hull Moving Average will note that the current level is 12.280775. The calculation uses the weighted moving average and it puts the emphasis on recent prices over older prices.

Technical traders focusing on Donchian Channels will note that the 20 period lower band reading is currently 9.04. The 20 period upper band reading is 12.4. Donchian Channels can be used to gauge the volatility of a market. This is a banded indicator akin to Bollinger Bands.

There are many factors that can affect the health of a company. This is one reason why stock trading can be extremely difficult at times. Because there are always so many things to take into consideration, it may be next to impossible to create a formula that will continually beat the market. Even after all the data has been scrutinized and the numbers have been crunched, the investor still has to make sense of the information and figure out what to do with it. Knowing how to use the information about publically traded companies can end up being the difference between handsome gains and devastating losses.